全文获取类型
收费全文 | 3218篇 |
免费 | 169篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 38篇 |
妇产科学 | 51篇 |
基础医学 | 454篇 |
口腔科学 | 137篇 |
临床医学 | 189篇 |
内科学 | 935篇 |
皮肤病学 | 55篇 |
神经病学 | 189篇 |
特种医学 | 105篇 |
外科学 | 457篇 |
综合类 | 6篇 |
预防医学 | 75篇 |
眼科学 | 36篇 |
药学 | 167篇 |
中国医学 | 7篇 |
肿瘤学 | 463篇 |
出版年
2023年 | 25篇 |
2022年 | 37篇 |
2021年 | 93篇 |
2020年 | 40篇 |
2019年 | 51篇 |
2018年 | 63篇 |
2017年 | 57篇 |
2016年 | 56篇 |
2015年 | 80篇 |
2014年 | 92篇 |
2013年 | 103篇 |
2012年 | 169篇 |
2011年 | 201篇 |
2010年 | 106篇 |
2009年 | 83篇 |
2008年 | 147篇 |
2007年 | 140篇 |
2006年 | 143篇 |
2005年 | 160篇 |
2004年 | 144篇 |
2003年 | 134篇 |
2002年 | 131篇 |
2001年 | 91篇 |
2000年 | 95篇 |
1999年 | 91篇 |
1998年 | 45篇 |
1997年 | 26篇 |
1996年 | 33篇 |
1995年 | 24篇 |
1994年 | 29篇 |
1993年 | 22篇 |
1992年 | 53篇 |
1991年 | 51篇 |
1990年 | 40篇 |
1989年 | 60篇 |
1988年 | 60篇 |
1987年 | 49篇 |
1986年 | 36篇 |
1985年 | 38篇 |
1984年 | 34篇 |
1983年 | 38篇 |
1982年 | 17篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 21篇 |
1978年 | 20篇 |
1977年 | 13篇 |
1975年 | 13篇 |
1974年 | 24篇 |
1970年 | 12篇 |
排序方式: 共有3404条查询结果,搜索用时 577 毫秒
991.
992.
Sakamoto I Yoda T Tsukahara H Imai H Enomoto S 《Cranio : the journal of craniomandibular practice》2000,18(4):264-271
The objective of this study was to investigate the effectiveness of temporomandibular joint arthrocentesis in acute and chronic closed lock patients. Eighteen patients with closed lock of the temporomandibular joint (TMJ) were treated with fine needle fiber arthroscopic observation following arthrocentesis. Maximal mouth opening (MMO) and intensity of pain (VAS) were evaluated at pretreatment and each posttreatment appointment (one week, one month, three months following treatment). The clinical and arthroscopic findings were analyzed categorizing two groups into: good (A) and poor (B) groups. At pretreatment there was no significance relative to age or the mean MMO and VAS between the groups, but the mean of duration of the symptoms in group B was significantly longer than in group A (P < 0.03). Group B showed more severe synovitis, adhesions, and chondromalacia than group A (P < 0.01). Results suggest that arthrocentesis is more effective in closed lock of short duration where there is less severe synovitis, adhesions, and chondromalacia. 相似文献
993.
OBJECTIVE: To evaluate the effectiveness, for patients who have only two embryos on day 2, of a two-step (consecutive) embryo transfer (ET) procedure in which a cleaved embryo is transferred on day 2 and a single blastocyst is transferred on day 5. DESIGN: Observational comparative study. SETTING: Private IVF clinic. PATIENT(S): Ninety two-step ET cycles were performed in patients who had two embryos on day 2 (two-step group). Ninety day-2 ET cycles were performed in age- and infertility-matched patients who had two embryos on day 2 (control group). INTERVENTION(S): Cleaved-ET, extended culture of one embryo, and a second transfer of a blastocyst. MAIN OUTCOME MEASURE(S): Implantation and pregnancy rates. RESULT(S): The pregnancy and implantation rates in the two-step group (respectively 33.3% and 17.2%) were significantly higher than those in the control group (18.9% and 9.4%). Thirty-nine of the patients in the two-step group (43.3%) could not proceed to the second step of ET because no viable blastocyst could be obtained, but four of them conceived anyway. CONCLUSION(S): Taking advantage of both day-2 ET and blastocyst transfer, two-step ET may be an effective option for ET in patients who have an insufficient number of embryos. 相似文献
994.
Kamata K Shinozaki K Okada M Seto Y Kobayashi S Sakae K Oseto M Natori K Shirato-Horikoshi H Katayama K Tanaka T Takeda N Taniguchi K 《Journal of medical virology》2005,76(1):129-136
Human noroviruses (NoVs), members of the genus Norovirus in the family Caliciviridae, are the leading agents of nonbacterial acute gastroenteritis worldwide. Human NoVs are currently divided into at least two genogroups, genogroup I (GI) and genogroup II (GII), each of which contains at least 14 and 17 genotypes. To explore the genetic and antigenic relationship among NoVs, we expressed the capsid protein of four genetically distinct NoVs, the GI/3 Kashiwa645 virus, the GII/3 Sanbu809 virus, the GII/5 Ichikawa754 virus, and the GII/7 Osaka10-25 virus in baculovirus expression system. An antigen enzyme-linked immunosorbent assay (ELISA) with hyperimmune serum against the four recombinant capsid proteins and characterized previously three capsid proteins derived from GI/1, GI/4, and GII/12 was developed to detect the NoVs antigen in stools. The antigen ELISA was highly specific to the homotypic strains, allowing assignment of a strain to a Norovirus genetic cluster within a genogroup. 相似文献
995.
996.
Sato K Sekiguchi S Fukumori T Kawagishi N Akamastu Y Enomoto Y Iwane T Fujimori K Sato A Satomi S 《Transplantation proceedings》2005,37(10):4343-4346
Middle hepatic vein reconstruction during the right-lobe living donor liver transplant procedure has been recognized to be a significant factor. We initially reconstructed only a single middle hepatic vein orifice draining into segment 8. In cases where the right-lobe liver graft has several major middle hepatic vein tributaries, including veins draining segment 5 that are remote from the right hepatic vein orifice, a long and thick interposition conduit is necessary for reconstruction. Among 11 consecutive adult patients who received a right-lobe liver graft without a middle hepatic vein at our institution, 8 underwent reconstruction of all major middle hepatic vein tributaries using a vein graft from the recipient's superficial femoral vein. The remaining 3 patients had no major middle hepatic vein tributaries. Posttransplant-computed tomography imagings showed increased liver mass with a patent superficial femoral vein graft in 8 patients. In the absence of a venous system from a deceased donor, a recipient superficial femoral vein offers an excellent size match to maintain the venous outflow of middle hepatic vein tributaries. Reconstruction with recipient superficial femoral vein plays an important role in maximizing liver function and minimizing morbidity in the early posttransplant period. 相似文献
997.
Murayama T Sato Y Wainai T Enomoto A Seo N Yoshino H Kobayashi E 《Transplantation proceedings》2005,37(10):4567-4570
In living donor liver transplantation, propofol, an intravenous anesthetic drug, has recently been used in both donors and recipients. Propofol is known to have intra- and extrahepatic metabolic pathways, but the effect of its continuous infusion during a long-term anhepatic state is yet to be determined. Recently, we successfully established a simplified pig model of the complete anhepatic state. In this state, we first evaluated hemodynamic parameters relating to the pharmacokinetics of continuously infused propofol (6 mg.kg(-1) x h(-1)). No significant changes in the concentration of hemoglobin or in hemodynamic parameters other than the heart rate were observed during the anhepatic phase when porpofol was continuously infused at the rate that maintains the state. Blood propofol concentrations in the mixed vein, artery, and portal vein were stable during the anhepatic phase. Finally, we confirmed the pharmacokinetics of continuously infused propofol using orthotropic liver transplantation in miniature pigs. The propofol concentration did not change markedly during the transplant procedure. In conclusion, the pharmacokinetics of continuously infused propofol was almost stable with and without the liver in pigs. Extrahepatic metabolism of propofol might help prevent changes in propofol concentrations. 相似文献
998.
Kawagishi N Satoh K Enomoto Y Akamatsu Y Sekiguchi S Fukumori T Fujimori K Satomi S 《Transplantation proceedings》2005,37(2):1205-1206
It is more difficult to control humoral rejection in living donor liver transplantations (LDLT) across the ABO blood group barrier than in matched or compatible combinations. We achieved excellent results in ABO-incompatible transplantation with novel immunosuppressive regimens and plasma exchange (PE). Among 82 LDLT were 10 cases of ABO-incompatible recipients, including three who were administered rituximab for rescue or prophylactic therapy. Pretransplantation PE was performed as necessary to maintain hemagglutinin titers below 1:16 and posttransplantation PE was performed when there were signs of hyperacute rejection associated with high titers. Induction immunosuppression consisted of FK506, steroid, mycophenolate mofetil (MMF), and rituximab. The first patient was administered rituximab with deoxyspergualin (DSG), steroid pulse therapy, and PE on postoperative day (POD) 7, because of biopsy-proven humoral acute rejection. The titers and LFTs improved drastically. The second and third patients were administered rituximab just after the operation with other routine immunosuppressants for prophylaxis of hyperacute rejection. The second patient showed a slight deterioration in LFTs with an elevated titer, which normalized after steroid pulse therapy and PE. The third patient had no episodes of rejection. At present, that is 27, 17, and 6 months after the operations respectively, the 3 transplant recipients are in stable condition. 相似文献
999.
1000.
Koizumi K Haraguchi S Hirata T Hirai K Mikami I Yamagishi S Okada D Kinoshita H Enomoto Y Nakajima Y Shimizu K 《Surgery today》2005,35(5):357-363
Purpose To access the clinical outcome of patients with superior sulcus tumor.Methods We reviewed the records of 16 patients who underwent surgery for a superior sulcus tumor between 1988 and 2003, focusing on the type of surgery.Results All 16 patients underwent en bloc lung and chest wall resection, which was done as pneumonectomy in 1 patient and lobectomy in 15. Complete resection was achieved in 11 patients, but incomplete resection was done in 5 patients because microscopic examination revealed positive surgical margins. Eight patients underwent partial vertebrectomy and 1 patient had combined resection of the subclavian artery. There was no postoperative mortality. All patients received pre- or postoperative adjuvant therapy, or both. The overall 5-year survival rate was 31.0%. The 5-year survival rate was higher after complete resection than after incomplete resection (59.3% vs 0%, P = 0.08). Patients who underwent complete resection for vertebral invasion and those who did not had 5-year survival rates of 66.7% and 0%, respectively (P = 0.17). Patients who underwent preoperative induction therapy followed by complete resection and those who did not had 5-year survival rates of 80% and 0%, respectively (P = 0.009).Conclusion Although superior sulcus tumors are still complex, preoperative induction therapy followed by complete resection seemed effective for prolonging survival. 相似文献